Good example of analysing behaviour by barriers and enablers. “Two studies carried out with the Centre for Behaviour Change examined factors affecting the purchase, repair, repurpose and disposal of clothes by people in the UK before and during the Covid-19 pandemic.”
I've been looking at a few industry reports on the future of biopharma as part of a course I'm on with INSEAD Business School on Business Strategy and Financial Performance. I thought I'd share some of my ramblings on Biopharma Futures. Expectations are high Pharmaceutical
companies are operating...
The COVID-19 pandemic has accelerated changes to our working world. What does this mean for pharma, and what must the industry do to keep pace? PwC - future of work for pharma costs - pressures on efficienct, increasing R&D costs sustainability and societal impact - pressure on companies to address...
Biopharma in 2020 has shown what it can achieve when it works at its best. How can the industry build on this renewed sense of purpose in the years ahead? McKinsey biopharma 2020 3 Overarching trends Operating under a spotlight - expectation of innovationNavigating protracted economic uncertainty -...
Stephen Casper - medical historian at Clarkson University - offers a worrying prediction for COVID for the end of 2022. The analogy for COVID-19 won't be influenza but 'tuberculosis before the discovery of antibiotics'. A new hospital specialty might even exist - looking after COVID patients - and they...
I've been fascinated by the psychology of panic buying and it is clearly an area for future research. It has an enormous impact on delivery infrastructure and I wonder if anyone has been tracking the data of the causes and the impact in the current fuel 'crisis'. A systematic review from last year identified...
A growing body of scientific evidence suggests that face masks can protect against COVID-19. There is, however, limited rigorous evidence on the extent to which mask-wearing is effective in reducing COVID-19 in a real-life situation with imperfect and inconsistent mask use. In Bangladesh, researchers...
Prime Minister Boris Johnson's 'freedom day' ending over a year of COVID-19 lockdown restrictions in England was marred on Monday by surging infections, warnings of supermarket shortages and his own forced self-isolation.
Outgoing U.N. aid chief Mark Lowcock slammed the Group of Seven wealthy nations on Monday for failing to come up with a plan to vaccinate the world against COVID-19, describing the G7 pledge to provide 1 billion doses over the next year as a "small step."
Reuters and the Minneapolis Star Tribune each won a Pulitzer Prize on Friday for journalism about racial inequities in U.S. policing, while the New York Times and the Atlantic were honored for chronicling the COVID-19 pandemic, the two topics that dominated last year's headlines.
All viruses, including SARS-CoV-2, the virus that causes COVID-19, change over time. Most changes have little to no impact on the virus’ properties. However, some changes may affect the virus’s properties, such as how easily it spreads, the associated disease severity, or the performance...
The latest coronavirus news updated every day including coronavirus cases, the latest news, features and interviews from New Scientist and essential information about the covid-19 pandemic
The speed and intensity of transitioning to mass online delivery of teaching has left in its wake a unique digital record, the patterns and trends of which reveal the story of the sector grappling to respond.
"The Bank of England said Britain's economy would grow by the most since World War Two this year and slowed the pace of its trillion dollar bond-purchasing programme, but stressed it was not reversing its stimulus." Strong indications finally of a bounce back in the economy highlight the devastating...
Global CO2 emissions from energy are seen rising nearly 5% this year, suggesting the economic rebound from COVID-19 could be "anything but sustainable" for the climate, the International Energy Agency said on Tuesday.
Covid-19 vaccines are still hard to come by in many places, but supply in the US will soon outpace demand.
About
I am a physician working in medical affairs at UCB, co-founder of OnExamination.com and 24hourlondon.co.uk, educationalist, brewer, and coder. All opinions are personal. This is also the home of The Crap Artist (Official) blog posts. Dr Dean Jenkins FRCP.
RSS feed